Partner 2 at 10 years: surgery should remain a valid option in intermediate-risk patients

This study analyzes the 10-year clinical and echocardiographic outcomes of the randomized PARTNER 2A trial, which compared transcatheter aortic valve implantation using transfemoral or transthoracic transapical or transaortic access with the SAPIEN XT prosthesis versus surgery in patients with severe symptomatic aortic stenosis and intermediate surgical risk.

Read More >>
SUBSCRIBE TO OUR MONTHLY NEWSLETTER.
Get to know our magazine